pemafibrate
Kowa Pharmaceuticals
[]
dr discusses the #prominent trial of #pemafibrate. #aha22 . it's about this specific drug not a strategy for tg lowering. but we have studied other fibrates for similar outcomes in past and gotten same results. here are her thoughts: 
Johns Hopkins Medicine. Associate Professor, Cardiology. Co-Editor in Chief @AJPCardio. #WomenHeartHealth #CardioObstetrics #cvPrev #echofirst She/her #BeKind